Back
ProShares UltraPro S&P500 Vs. Aligos Therapeutics Industry Stock Comparison
Sell
42
UPRO
ProShares UltraPro S&P500
Last Price:
$92.93
Seasonality Move:
9.12%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
42
ProShares UltraPro S&P500 (UPRO)
is a Sell
Is ProShares UltraPro S&P500 a Buy, Sell or Hold?
-
The current ProShares UltraPro S&P500 [UPRO] share price is $92.91. The Score for UPRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
UPRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UPRO Stock Price Chart
What is ProShares UltraPro S&P500's stock price today?
-
The ProShares UltraPro S&P500 share price today is $92.91The current trend is moderately bearish and UPRO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $41.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
UPRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 46.78 | Sell |
| Chaikin Money Flow: | 1170101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.7 - 98.84) | Sell |
| Bollinger Bands (100): | (78.45 - 94.65) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 73.75 | Buy |
| Chaikin Money Flow: | -154898 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.72 - 37.64) | Buy |
| Bollinger Bands (100): | (6.81 - 25.85) | Buy |
UPRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.7 | Sell |
| 20-day SMA: | 96.21 | Sell |
| 50-day SMA: | 92.81 | Buy |
| 200-day SMA: | 79.05 | Buy |
| 8-day EMA: | 94.17 | Sell |
| 20-day EMA: | 94.76 | Sell |
| 50-day EMA: | 92.5 | Buy |
| 200-day EMA: | 79.84 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.54 | Buy |
| 20-day SMA: | 33.12 | Buy |
| 50-day SMA: | 21.28 | Buy |
| 200-day SMA: | 16.61 | Buy |
| 8-day EMA: | 38.79 | Buy |
| 20-day EMA: | 33.47 | Buy |
| 50-day EMA: | 25.09 | Buy |
| 200-day EMA: | 18.34 | Buy |
ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
ProShares UltraPro S&P500 Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||